Natasha S Crowcroft
Overview
Explore the profile of Natasha S Crowcroft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
3559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crowcroft N, Minta A, Antoni S, Ho L, Perea W, Mulders M, et al.
Rev Panam Salud Publica
. 2024 Dec;
48():e90.
PMID: 39687257
Measles and rubella have long been recognized as priorities for disease prevention because of their devastating consequences for child health; hence, all World Health Organization (WHO) regions currently have a...
2.
Minta A, Ferrari M, Antoni S, Lambert B, Sayi T, Hsu C, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Nov;
73(45):1036-1042.
PMID: 39541251
Measles vaccination effectively prevents measles, a highly contagious disease that can cause severe complications and death and requires high population immunity to interrupt transmission. This report describes measles elimination progress...
3.
Lambach P, Silal S, Sbarra A, Crowcroft N, Frey K, Ferrari M, et al.
Vaccine
. 2024 Sep;
42(26):126307.
PMID: 39276622
The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28...
4.
Crowcroft N, Minta A, Bolotin S, Cernuschi T, Ariyarajah A, Antoni S, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066457
Measles is a highly infectious disease leading to high morbidity and mortality impacting people's lives and economies across the globe. The measles vaccine saves more lives than any other vaccine...
5.
Fell D, Russell M, Fung S, Swayze S, Chung H, Buchan S, et al.
J Infect Dis
. 2024 Jul;
230(1):e80-e92.
PMID: 39052720
Background: Randomized trials conducted in low- and middle-income settings demonstrated efficacy of influenza vaccination during pregnancy against influenza infection among infants <6 months of age. However, vaccine effectiveness (VE) estimates...
6.
Ou A, Zimmerman L, Alexander Jr J, Crowcroft N, OConnor P, Knapp J
MMWR Morb Mortal Wkly Rep
. 2024 Feb;
73(8):162-167.
PMID: 38421933
Rubella virus is a leading cause of vaccine-preventable birth defects. Infection during pregnancy can result in miscarriage, fetal death, stillbirth, or a constellation of birth defects, including cataracts, deafness, heart...
7.
Chung H, Campitelli M, Buchan S, Campigotto A, Crowcroft N, Gubbay J, et al.
Euro Surveill
. 2024 Feb;
29(8).
PMID: 38390652
BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe...
8.
Validating pertussis data measures using electronic medical record data in Ontario, Canada 1986-2016
McBurney S, Kwong J, Brown K, Rudzicz F, Chen B, Candido E, et al.
Vaccine X
. 2024 Jan;
15:100408.
PMID: 38161988
Background: Pertussis is a reportable disease in many countries, but ascertainment bias has limited data accuracy. This study aims to validate pertussis data measures using a reference standard that incorporates...
9.
McBurney S, Kwong J, Brown K, Rudzicz F, Wilton A, Crowcroft N
PLoS One
. 2023 Dec;
18(12):e0273205.
PMID: 38039303
An underestimation of pertussis burden has impeded understanding of transmission and disallows effective policy and prevention to be prioritized and enacted. Capture-recapture analyses can improve burden estimates; however, uncertainty remains...
10.
Minta A, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Nov;
72(46):1262-1268.
PMID: 37971951
Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no...